1
|
Chen G, Li Q, Chen J, Huang F, Qin C, He X. Shu Fu Pai ® Protein Short Peptides Beverage for the treatment of hypoalbuminemia in liver cirrhosis. Am J Transl Res 2023; 15:5723-5729. [PMID: 37854233 PMCID: PMC10579008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2023] [Accepted: 08/23/2023] [Indexed: 10/20/2023]
Abstract
OBJECTIVE To investigate the clinical efficacy of Shu Fu Pai® Protein Short Peptides Beverage in the treatment of hypoalbuminemia in liver cirrhosis. METHODS A retrospective analysis was conducted on 289 patients with liver cirrhosis and hypoalbuminemia who were admitted to Deyang People's Hospital between April 2021 and April 2023. Among them, 148 patients treated with Shu Fu Pai® Protein Short Peptides Beverage were assigned as an observation group and 141 patients treated with intravenous human albumin were the control group. Liver function, coagulation function before and after treatment, and complications after treatment were compared between the two groups. The patients whose albumin levels did not increase after treatment were counted, and the influencing factors were analyzed using univariate and multivariate analyses. RESULTS After treatment, there was a significant improvement in liver function, serum albumin level, Child-Pugh score, inflammatory markers, and coagulation function in both groups (all P=0.001). However, no significant difference was found in the peripheral blood indicators between the two groups (P>0.05). Also, there was no significant difference in complications between the two groups (P=0.194). Logistic regression analysis showed that age, pre-treatment serum albumin level, disease type, and abnormal liver function markers were independent factors affecting the treatment outcome of hypoalbuminemia, and treatment regimen was not an influencing factor. CONCLUSION Shu Fu Pai® Protein Short Peptides Beverage for hypoalbuminemia in liver cirrhosis is not inferior to intravenous human albumin for improving liver function, inflammatory markers, and coagulation function. The therapeutic effect on hypoproteinemia is independent of type of treatment regimen, which suggests that Shu Fu Pai® Protein Short Peptides Beverage is an effective treatment for hypoalbuminemia in liver cirrhosis, without an increased risk of complications.
Collapse
Affiliation(s)
- Gao Chen
- Department of Infection, Deyang People’s HospitalDeyang 618000, Sichuan, China
| | - Qian Li
- Department of Infection, Deyang People’s HospitalDeyang 618000, Sichuan, China
| | - Junli Chen
- Department of Medical Records, Zhongjiang County Second People’s HospitalDeyang 618107, Sichuan, China
| | - Fei Huang
- Department of Infection, Deyang People’s HospitalDeyang 618000, Sichuan, China
| | - Chunjun Qin
- Department of Infection, Deyang People’s HospitalDeyang 618000, Sichuan, China
| | - Xianya He
- Department of Infection, Deyang People’s HospitalDeyang 618000, Sichuan, China
| |
Collapse
|
2
|
Waich A, Ruiz Severiche J, Manrique Andrade M, Castañeda Aza JA, Castellanos Ramírez JC, Otero Mendoza L, Restrepo Gualteros SM, Panqueva OP, Hidalgo Martínez P. Prevalence of sleep apnea in children and adolescents in Colombia according to the national health registry 2017–2021. PLoS One 2022; 17:e0273324. [PMID: 36044460 PMCID: PMC9432726 DOI: 10.1371/journal.pone.0273324] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2022] [Accepted: 08/06/2022] [Indexed: 11/17/2022] Open
Abstract
Objective To describe the sociodemographic and epidemiological characteristics of diagnosis and treatment of pediatric patients with sleep apnea, both central and obstructive, in Colombia between 2017 and 2021. Methods Observational, descriptive, cross-sectional, epidemiological study using the International Classification of Diseases and Related Health Problems as search terms for sleep apnea, based on SISPRO, the Colombian national health registry. Stratification by gender and age groups was performed. We also generated data of the amount of diagnostic and therapeutic procedures performed. A map of prevalence by place of residency was performed. Results National records report 15200 cases of SA between 2017 and 2021, for an estimated prevalence of 21.1 cases by 100000 inhabitants in 2019 the year with the most cases (4769), being more frequent and in the 6 to 11 age group and in males, with a male to female ratio of 1.54:1. The number of cases declined in 2020 and 2021. The map showed a concentration of cases in the more developed departments of the country. Discussion This is the first approximation to a nation-wide prevalence of sleep apnea in Colombia which is lower to what is found in the literature worldwide, including studies performed in Latin America and in Colombia, this could reflect sub diagnosis and sub report. The fact that the highest prevalence was found in males and in the 6–11 age group is consistent with reports in literature. The decrease in cases in 2020 and 2021 could be related to the COVID-19 pandemic impact in sleep medicine services.
Collapse
Affiliation(s)
- Alan Waich
- Sleep disorders research group, School of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia
- * E-mail:
| | - Juanita Ruiz Severiche
- Sleep disorders research group, School of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia
| | | | | | | | - Liliana Otero Mendoza
- Sleep disorders research group, School of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia
- Center of Dental Research, Pontificia Universidad Javeriana, Bogotá, Colombia
| | - Sonia Maria Restrepo Gualteros
- Sleep disorders research group, School of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia
- Sleep clinic, Hospital Universitario San Ignacio, Bogotá, Colombia
- Departament of Pediatrics, Hospital Universitario San Ignacio, Pontificia Universidad Javeriana, Bogotá, Colombia
| | - Olga Patricia Panqueva
- Sleep disorders research group, School of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia
- Sleep clinic, Hospital Universitario San Ignacio, Bogotá, Colombia
- Departament of Pediatrics, Hospital Universitario San Ignacio, Pontificia Universidad Javeriana, Bogotá, Colombia
| | - Patricia Hidalgo Martínez
- Sleep disorders research group, School of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia
- Sleep clinic, Hospital Universitario San Ignacio, Bogotá, Colombia
- Departament of Internal Medicine, Hospital Universitario San Ignacio, Pontificia Universidad Javeriana, Bogotá, Colombia
| |
Collapse
|